Capital Fund Management (CFM)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-21,914
Closed -$3.88M 1741
2020
Q1
$3.88M Buy
+21,914
New +$4.13M 0.06% 355
2019
Q2
Sell
-4,605
Closed -$638K 2033
2019
Q1
$674K Sell
4,605
-65,812
-93% -$9.54M 0.01% 1150
2018
Q4
$9.41M Buy
+70,417
New +$11.5M 0.08% 332
2018
Q3
Sell
-260,215
Closed -$47.8M 2406
2018
Q2
$43.4M Buy
260,215
+105,761
+68% +$17M 0.23% 118
2018
Q1
$26M Sell
154,454
-220,242
-59% -$36.9M 0.16% 186
2017
Q4
$61.3M Buy
374,696
+146,500
+64% +$26.3M 0.34% 60
2017
Q3
$46.8M Buy
228,196
+130,044
+132% +$30.2M 0.34% 68
2017
Q2
$23.9M Buy
+98,152
New +$23.1M 0.19% 149
2016
Q3
Sell
-56,031
Closed -$13.7M 1875
2016
Q2
$12.9M Buy
+56,031
New +$12.9M 0.12% 208
2016
Q1
Sell
-8,344
Closed -$2.61M 1983
2015
Q4
$2.61M Buy
+8,344
New +$2.48M 0.03% 603
2014
Q4
Sell
-1,700
Closed -$425K 1871
2014
Q3
$410K Buy
+1,700
New +$380K ﹤0.01% 1218

Other funds holding AGN

Capital Fund Management (CFM)'s AGN Position: Q2 2020 in Review

Capital Fund Management (CFM) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 21,914 shares — an estimated $3.88M sold.

Capital Fund Management (CFM) first reported a position in AGN in Q3 2014 and held it in 11 quarters. The position peaked at $61.3M in Q4 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Capital Fund Management (CFM) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 21,914 Allergan plc shares in Q2 2020, an estimated $3.88M.
  • Capital Fund Management (CFM) first reported a position in Allergan plc in Q3 2014 and held it in 11 quarters.
  • Capital Fund Management (CFM)'s Allergan plc position peaked at $61.3M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2020, filed 13 Aug 2020.